| Literature DB >> 30646170 |
Leslie R M Hausmann1,2, Ada Youk1,3, C Kent Kwoh4,5, Rollin M Gallagher6,7, Debra K Weiner2,8, Ernest R Vina4,5, D Scott Obrosky1,2, Genna T Mauro1, Shauna McInnes1, Said A Ibrahim6,7,9.
Abstract
Importance: Positive psychological interventions for improving health have received increasing attention recently. Evidence on the impact of such interventions on pain, and racial disparities in pain, is limited. Objective: To assess the effects of a positive psychological intervention on pain and functional difficulty in veterans with knee osteoarthritis. Design, Setting, and Participants: The Staying Positive With Arthritis Study is a large, double-blinded randomized clinical trial powered to detect race differences in self-reported pain in response to a positive psychological intervention compared with a neutral control intervention. Data were collected from 2 urban Veterans Affairs medical centers. Participants included non-Hispanic white and non-Hispanic African American patients aged 50 years or older with a diagnosis of osteoarthritis. Mailings were sent to 5111 patients meeting these criteria, of whom 839 were fully screened, 488 were eligible, and 360 were randomized. Enrollment lasted from July 8, 2015, to February 1, 2017, with follow-up through September 6, 2017. Interventions: The intervention comprised a 6-week series of evidence-based activities to build positive psychological skills (eg, gratitude and kindness). The control program comprised similarly structured neutral activities. Programs were delivered via workbook and weekly telephone calls with interventionists. Main Outcomes and Measures: The primary outcomes were self-reported pain and functional difficulty measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC; range 0-100). Secondary outcomes included affect balance and life satisfaction.Entities:
Mesh:
Year: 2018 PMID: 30646170 PMCID: PMC6324470 DOI: 10.1001/jamanetworkopen.2018.2533
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Staying Positive With Arthritis Study Inclusion and Exclusion Criteria for Initial Mailing and Full Study
| Inclusion | Exclusion |
|---|---|
| Eligibility criteria for initial mailing (based on VA electronic medical record) | |
| Aged ≥50 y | Deceased |
| Non-Hispanic white or non-Hispanic African American race | Nonveteran |
| Had a primary care appointment at a participating site in the past 12 mo | Inflammatory arthritis (rheumatoid arthritis [ |
| Osteoarthritis ( | Alzheimer disease and dementia ( |
| Eligibility criteria for enrollment (based on telephone screen) | |
| Aged ≥50 y | Self-reported serious problems with hearing, eyesight, or memory |
| Non-Hispanic white or non-Hispanic African American race | Diagnosed with any type of arthritis other than osteoarthritis or degenerative arthritis |
| Receives primary care at a participating site | Treated for cancer in the last 3 y |
| Frequent pain characteristic of symptomatic knee osteoarthritis[ | Had a steroid injection for knee pain in the past 3 mo |
| Pain in worst knee during the past wk rated as ≥4 on a 0-10 scale | Had a knee replacement in the past 3 mo |
| Speak, read, and write in English | Plan to have a knee replacement in the next 6 mo |
| Self-reported inability to complete study-related telephone calls and program activities that involve reading and writing | |
| No reliable telephone number | |
| Answering ≥2 items incorrectly on a 6-item screener for cognitive impairment[ |
Abbreviations: ICD-9, International Classification of Diseases, Ninth Revision; VA, Veterans Affairs.
Eligibility was determined based on self-reported responses to a screening survey.
Figure 1. CONSORT Flow Diagram for the Staying Positive With Arthritis Study
aReasons for ineligibility are provided in eTable 1 in Supplement 2.
bRandomization was at the patient level, stratified by site and self-reported race.
cDetails on reasons for missing data points are provided in eTable 2 and eTable 3 in Supplement 2.
Baseline Characteristics by Treatment Group and Race
| Variable | No. (%) | ||||
|---|---|---|---|---|---|
| Total (N = 360) | Treatment Group | Participant Race | |||
| Positive (n = 180) | Control (n = 180) | White (n = 180) | African American (n = 180) | ||
| Age, mean (SD), y | 64.2 (8.8) | 64.4 (9.4) | 64.1 (8.1) | 65.9 (9.2) | 62.6 (8.0) |
| BMI, mean (SD) | 31.8 (6.5) | 31.8 (6.4) | 31.9 (6.6) | 32.4 (6.7) | 31.3 (6.3) |
| Female | 85 (23.6) | 44 (24.4) | 41 (22.8) | 42 (23.3) | 43 (23.9) |
| Site | |||||
| Site A | 180 (50.0) | 90 (50.0) | 90 (50.0) | 90 (50.0) | 90 (50.0) |
| Site B | 180 (50.0) | 90 (50.0) | 90 (50.0) | 90 (50.0) | 90 (50.0) |
| Married or living with partner | 164 (45.6) | 80 (44.4) | 84 (46.7) | 99 (55.0) | 65 (36.1) |
| Employment status | |||||
| Employed | 88 (24.4) | 46 (25.6) | 42 (23.3) | 38 (21.1) | 50 (27.8) |
| Retired | 146 (40.6) | 72 (40.0) | 74 (41.1) | 92 (51.1) | 54 (30.0) |
| Disabled/unemployed/other | 126 (35.0) | 62 (34.4) | 64 (35.6) | 50 (27.8) | 76 (42.2) |
| Income, $ | |||||
| <20 000 | 103 (28.6) | 48 (26.7) | 55 (30.6) | 36 (20.0) | 67 (37.2) |
| 20 000-39 999 | 100 (27.8) | 52 (28.9) | 48 (26.7) | 44 (24.4) | 56 (31.1) |
| ≥40 000 | 136 (37.8) | 67 (37.2) | 69 (38.3) | 88 (48.9) | 48 (26.7) |
| Do not know/refused | 21 (5.8) | 13 (7.2) | 8 (4.4) | 12 (6.7) | 9.0 (5.0) |
| Education | |||||
| ≤High school | 109 (30.3) | 56 (31.1) | 53 (29.4) | 49 (27.2) | 60 (33.3) |
| Some college | 161 (44.7) | 75 (41.7) | 86 (47.8) | 77 (42.8) | 84 (46.7) |
| ≥4 y degree | 90 (25.0) | 49 (27.2) | 41 (22.8) | 54 (30.0) | 36 (20.0) |
| Adequate health literacy | 284 (78.9) | 138 (76.7) | 146 (81.1) | 145 (80.6) | 139 (77.2) |
| Good, very good, or excellent self-rated health | 218 (60.6) | 108 (60.0) | 110 (61.1) | 124 (68.9) | 94 (52.2) |
| Charlson comorbidity index (self-report) | |||||
| 0-1 | 104 (28.9) | 52 (28.9) | 52 (28.9) | 49 (27.2) | 55 (30.6) |
| 2-3 | 121 (33.6) | 61 (33.9) | 60 (33.3) | 55 (30.6) | 66 (36.7) |
| ≥4 | 135 (37.5) | 67 (37.2) | 68 (37.8) | 76 (42.2) | 59 (32.8) |
| Pain rating on 0-10 scale, mean (SD) | 7.2 (1.7) | 7.2 (1.6) | 7.3 (1.7) | 6.9 (1.7) | 7.6 (1.5) |
| Anxiety disorder (self-report) | 141 (39.2) | 66 (36.7) | 75 (41.7) | 72 (40.0) | 69 (38.3) |
| Depressive disorder (self-report) | 166 (46.1) | 78 (43.3) | 88 (48.9) | 78 (43.3) | 88 (48.9) |
| Being treated for mental health or emotional condition (self-report) | 122 (33.9) | 51 (28.3) | 71 (39.4) | 64 (35.6) | 58 (32.2) |
| No. of treatments currently being used for joint paint or arthritis, mean (SD) | |||||
| Pharmacological (possible range: 0-6) | 1.6 (1.0) | 1.5 (1.0) | 1.6 (1.1) | 1.6 (1.0) | 1.6 (1.1) |
| Nonpharmacological or alternative (possible range: 0-13) | 3.1 (2.0) | 3.1 (2.0) | 3.1 (2.0) | 3.2 (2.1) | 3.1 (1.9) |
| Radiographic evidence of OA | |||||
| No x-ray or MRI on file | 115 (31.9) | 57 (31.7) | 58 (32.2) | 64 (35.6) | 51 (28.3) |
| X-ray or MRI with no indication of OA | 16 (4.4) | 8 (4.4) | 8 (4.4) | 9 (5.0) | 7 (3.9) |
| X-ray or MRI on file with indication of OA | 229 (63.6) | 115 (63.9) | 114 (63.3) | 107 (59.4) | 122 (67.8) |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); MRI, magnetic resonance imaging; OA, osteoarthritis.
Count of the following treatments reportedly being used at baseline: acetaminophen, nonsteroidal anti-inflammatory drugs, topical nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 selective inhibitors, opioids, and hyaluronic acid or steroid injections.
Count of the following treatments reportedly being used at baseline: acupuncture, acupressure, or massage therapy; chiropractic care; homeopathy or naturopathy; physical therapy; water- or land-based exercise; health supplements for joint pain; vitamins; herbs; topical creams or oils; copper bracelets or magnets; yoga, tai chi, chi gong, pilates; relaxation or mind-body activities; and spiritual activities.
No x-ray or MRI on file and x-ray or MRI with no indication of OA were combined to create a dichotomous indicator of radiographic evidence of OA (no or yes) for analyses.
Change in Self-reported Pain and Functional Difficulty in White and African American Patients With Knee or Hip Osteoarthritis After Completing a 6-Week Positive Psychological Intervention or Neutral Control Program
| Outcomes | Positive Psychological Intervention | Neutral Control Program | Race × Program × Time Interaction | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 1 mo | 3 mo | 6 mo | Baseline | 1 mo | 3 mo | 6 mo | χ2 | ||
| Pain (WOMAC) | ||||||||||
| White | 1.03 | .79 | ||||||||
| No. | 89 | 82 | 79 | 79 | 88 | 73 | 79 | 82 | ||
| Mean (SD) | 45.2 (15.7) | 42.4 (15.8) | 40.1 (16.9) | 39.2 (18.0) | 45.1 (17.3) | 42.3 (21.8) | 40.8 (18.8) | 39.0 (18.7) | ||
| Change from baseline | −2.8 | −5.2 | −6.0 | −2.8 | −4.3 | −6.1 | ||||
| African American | ||||||||||
| No. | 90 | 74 | 76 | 77 | 90 | 76 | 74 | 71 | ||
| Mean (SD) | 55.2 (16.7) | 48.8 (20.8) | 47.8 (20.6) | 47.4 (23.0) | 49.7 (18.6) | 44.8 (20.1) | 46.0 (19.2) | 44.5 (20.9) | ||
| Change from baseline | −6.4 | −7.4 | −7.8 | −4.9 | −3.7 | −5.1 | ||||
| Functional difficulty (WOMAC) | ||||||||||
| White | 3.09 | .38 | ||||||||
| No. | 89 | 82 | 78 | 77 | 85 | 68 | 73 | 79 | ||
| Mean (SD) | 43.6 (17.1) | 40.1 (16.3) | 39.9 (17.3) | 40.6 (17.5) | 44.2 (17.9) | 40.0 (22.0) | 40.5 (20.0) | 39.1 (18.7) | ||
| Change from baseline | −3.6 | −3.7 | −3.1 | −4.1 | −3.6 | −5.1 | ||||
| African American | ||||||||||
| No. | 88 | 74 | 75 | 75 | 89 | 74 | 74 | 69 | ||
| Mean (SD) | 52.3 (17.4) | 49.6 (22.1) | 47.0 (20.1) | 47.3 (21.9) | 47.1 (19.1) | 45.9 (19.7) | 46.1 (19.4) | 45.1 (21.0) | ||
| Change from baseline | −2.7 | −5.3 | −5.0 | −1.3 | −1.1 | −2.1 | ||||
Abbreviation: WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
Means shown are unadjusted.
P values are based on χ2 tests of the 3-way interaction of program, race, and time from linear mixed models controlling for study site.
Higher scores indicate worse symptoms and negative change in scores indicates improvement.
Figure 2. Mean Affect Balance by Race and Treatment Arm Over Time
These means are provided to aid in interpretation of the significant interaction between treatment group, race, and time for affect balance (positive − negative affect scores), χ23 = 8.64; P = .03. Among white participants, affect balance decreased from baseline to 1 month in the positive group, but increased over the same time in the control group. Among African American participants, affect balance decreased slightly at 1 month in the control group, and steadily declined over each time point in the positive group.